{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:36:23Z","timestamp":1768462583391,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","theclinics.com","surgical.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.suc.2014.07.010","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T04:01:28Z","timestamp":1407470488000},"page":"1059-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unusual Presentations of Melanoma"],"prefix":"10.1016","volume":"94","author":[{"given":"Vernon K.","family":"Sondak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2014.07.010_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma. A summary of 84,836 cases from the past decade","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1542\/peds.2012-2520","article-title":"Incidence of childhood and adolescent melanoma in the United States: 1973-2009","volume":"131","author":"Wong","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.suc.2014.07.010_bib3","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.21835","article-title":"Metastatic melanoma to lymph nodes in patients with unknown primary sites","volume":"106","author":"Cormier","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.2007.14.0285","article-title":"Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma","volume":"26","author":"Lee","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/annonc\/mdt411","article-title":"Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas","volume":"25","author":"Egberts","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib6","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1200\/jco.2010.28.15_suppl.8517","article-title":"Should unknown primary melanomas be excluded from adjuvant trials? Insights from SWOG S0008","volume":"28","author":"Sondak","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib7","doi-asserted-by":"crossref","first-page":"e66953","DOI":"10.1371\/journal.pone.0066953","article-title":"Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour","volume":"8","author":"Weide","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.suc.2014.07.010_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/1078-0432.CCR-1103-3","article-title":"A\u00a0pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanoma","volume":"10","author":"Kirkwood","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2014.07.010_bib9","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2011.41.3799","article-title":"Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma","volume":"30","author":"Eggermont","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.suc.2014.07.010_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008955.pub2","article-title":"Interferon alpha for the adjuvant treatment of cutaneous melanoma","author":"Mocellin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.suc.2014.07.010_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1470-2045(12)70138-9","article-title":"Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial","volume":"13","author":"Burmeister","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2014.07.010_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1470-2045(14)70012-9","article-title":"Safety and efficacy of vemurafenib in BRAF V600E and BRAF V600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study","volume":"15","author":"McArthur","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib14","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2014.07.010_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti\u2013PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2014.07.010_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2014.07.010_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archderm.140.1.99","article-title":"Primary dermal melanoma. A distinct subtype of melanoma","volume":"140","author":"Swetter","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.suc.2014.07.010_bib18","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archdermatol.2007.16","article-title":"Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma","volume":"144","author":"Cassarino","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.suc.2014.07.010_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0b013e31815b8288","article-title":"Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma","volume":"32","author":"Lyle","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.suc.2014.07.010_bib21","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1200\/JCO.2008.18.9845","article-title":"Improved survival for stage IV melanoma from an unknown primary site","volume":"27","author":"Lee","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.2010-3501","article-title":"Ultraviolet radiation: a hazard to children and adolescents","volume":"127","author":"Council on Environmental Health","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.suc.2014.07.010_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.2012-2404","article-title":"Teens and indoor tanning: a cancer prevention opportunity for pediatricians","volume":"131","author":"Balk","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.suc.2014.07.010_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/PAS.0000000000000198","article-title":"Histomorphologic assessment and interobserver diagnostic reproducibility of atypical Spitzoid melanocytic neoplasms with long-term follow-up","volume":"38","author":"Gerami","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.suc.2014.07.010_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.6004\/jnccn.2013.0087","article-title":"Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults","volume":"11","author":"Reed","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.suc.2014.07.010_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cncr.22818","article-title":"Melanoma in the young: differences and similarities with adult melanoma. A case-matched controlled analysis","volume":"110","author":"Livestro","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib27","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1002\/cncr.28291","article-title":"Is pediatric melanoma always malignant?","volume":"119","author":"Coit","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib28","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1200\/JCO.2006.08.8310","article-title":"Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base","volume":"25","author":"Lange","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib29","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1245\/s10434-012-2554-5","article-title":"The unique clinical characteristics of melanoma diagnosed in children","volume":"19","author":"Han","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib30","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1002\/cncr.28289","article-title":"Pediatric melanoma: analysis of an international registry","volume":"119","author":"Averbook","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaad.2012.12.953","article-title":"Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children","volume":"68","author":"Cordero","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2014.07.010_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(12)60815-0","article-title":"Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumors: a retrospective cohort study","volume":"380","author":"Pearce","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2014.07.010_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.cmr.0000131014.79262.bf","article-title":"Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma","volume":"14","author":"Berg","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.suc.2014.07.010_bib34","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/jid.2008.422","article-title":"Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT","volume":"129","author":"Daniotti","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.suc.2014.07.010_bib35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5858\/2011-0048-RAIR.1","article-title":"Update on fluorescence in situ hybridization in melanoma: state of the art","volume":"135","author":"Gerami","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.suc.2014.07.010_bib36","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/PAS.0b013e31828fc283","article-title":"Outcomes of atypical Spitz tumors with chromosomal copy numbers aberrations and conventional melanomas in children","volume":"37","author":"Gerami","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.suc.2014.07.010_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/gcc.20753","article-title":"Deletion at chromosome arm 9p in relation to BRAF\/NRAS mutations and prognostic significance for primary melanoma","volume":"49","author":"Conway","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib38","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0b013e3182753de6","article-title":"Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations","volume":"37","author":"Gerami","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.suc.2014.07.010_bib39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24047","article-title":"The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution","volume":"115","author":"Ludgate","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0560.2011.01853.x","article-title":"Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients","volume":"39","author":"Mills","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.suc.2014.07.010_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.seminoncol.2009.07.001","article-title":"Melanoma in pediatric, adolescent, and young adult patients","volume":"36","author":"Kirkwood","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib42","first-page":"1","article-title":"High-risk surgically resected pediatric melanoma and adjuvant interferon therapy","volume":"43","author":"Cao","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cncr.20860","article-title":"The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma","volume":"103","author":"Navid","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00280-010-1326-9","article-title":"Pharmacokinetic\/pharmacodynamics analysis of adjuvant pegylated interferon \u03b1-2b in patients with resected high-risk melanoma","volume":"67","author":"Daud","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.suc.2014.07.010_bib45","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib46","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/1055-9965.EPI-09-1267","article-title":"Epidemiology of extracutaneous melanoma in the Netherlands","volume":"19","author":"Koomen","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.suc.2014.07.010_bib47","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1200\/JCO.2013.50.3227","article-title":"Targeting activated KIT signaling for melanoma therapy","volume":"31","author":"Bastian","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib48","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-11-1987","article-title":"Sunitinib therapy for melanoma patients with KIT mutations","volume":"18","author":"Minor","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2014.07.010_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2013.211","article-title":"Comparison of molecular abnormalities in vulvar and vaginal melanomas","author":"Aulmann","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.suc.2014.07.010_bib50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.sla.0000225114.56565.f9","article-title":"The role of abdominoperineal resection as surgical therapy for anorectal melanoma","volume":"244","author":"Yeh","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2014.07.010_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1245\/s10434-009-0705-0","article-title":"Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?","volume":"17","author":"Iddings","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CCO.0b013e32830b0dda","article-title":"Management of melanomas of the female genital tract","volume":"20","author":"Sugiyama","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/RLU.0b013e3181becdaf","article-title":"Sentinel node mapping in vulvovaginal melanoma using SPECT\/CT lymphoscintigraphy","volume":"34","author":"Kobayashi","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.suc.2014.07.010_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0b013e31828d73bf","article-title":"Radiation therapy for mucosal melanoma of the head and neck","author":"Christopherson","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib55","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/ijc.28625","article-title":"Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis","volume":"134","author":"Bishop","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.suc.2014.07.010_bib56","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1158\/1078-0432.CCR-13-0739","article-title":"Phase II randomized trial comparing high-dose IFN-\u03b12b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma","volume":"19","author":"Lian","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2014.07.010_bib57","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas","volume":"19","author":"Griewank","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2014.07.010_bib58","first-page":"18","article-title":"Progress in the studies of etiology, epidemiology and pathogenesis of ocular melanomas","volume":"26","author":"Hu","year":"2011","journal-title":"Eye Sci"},{"key":"10.1016\/j.suc.2014.07.010_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1442-9071.2008.01717.x","article-title":"The hunt for the secrets of uveal melanoma","volume":"36","author":"Shields","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.suc.2014.07.010_bib60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.suc.2014.07.010_bib61","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2014.07.010_bib62","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.suc.2014.07.010_bib63","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ophtha.2010.05.023","article-title":"Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.suc.2014.07.010_bib64","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.suc.2014.07.010_bib65","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1158\/1078-0432.CCR-13-2007","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations\u2014letter","volume":"19","author":"Weber","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2014.07.010_bib66","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.suc.2014.07.010_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamadermatol.2013.1529","article-title":"Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression. A clue to a hereditary tumor syndrome","volume":"49","author":"Busam","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.suc.2014.07.010_bib68","first-page":"517032","article-title":"Long-term followup comparing two treatment dosing strategies of (125)I plaque radiotherapy in the management of small\/medium posterior uveal melanoma","volume":"2013","author":"Murray","year":"2013","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.suc.2014.07.010_bib69","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/bjophthalmol-2013-303671","article-title":"Prospective study of sentinel lymph node biopsy for conjunctival melanoma","volume":"97","author":"Cohen","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.suc.2014.07.010_bib70","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ophtha.2009.04.044","article-title":"Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis","volume":"116","author":"Lane","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.suc.2014.07.010_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jso.23361","article-title":"Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries","volume":"108","author":"Ryu","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib72","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jso.23501","article-title":"Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience","volume":"109","author":"Forster","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2014.07.010_bib73","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/cncr.28480","article-title":"Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options","volume":"120","author":"Agarwala","year":"2014","journal-title":"Cancer"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610914001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610914001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T23:24:51Z","timestamp":1649892291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610914001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0039610914001091"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2014.07.010","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusual Presentations of Melanoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2014.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}